Anti-WT1/HLA-specific antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10836829
APP PUB NO 20170101473A1
SERIAL NO

15288145

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antibodies or fragments thereof binding to human WT1/HLA. In particular, the present invention relates to antibodies or fragments thereof that have combined improved and/or beneficial properties, and are therefore suited for clinical development.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • IMMATICS BIOTECHNOLOGIES GMBH; MORPHOSYS AG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hartlepp, Klaus Felix Munich, DE 6 2
Kraus, Alexandra Munich, DE 10 31
Mahr, Andrea Tuebingen, DE 439 3325
Maurer, Dominik Reutlingen, DE 68 166
Wagner, Claudia Tuebingen, DE 72 274
Weinschenk, Toni Aichwald, DE 760 8126

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 17, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 17, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00